Looking for Sentiment Analysis? Discover the most popular stocks on Reddit by using our Sentiment Tracker
Market Cap 1.44B P/E - EPS this Y 8.20% Ern Qtrly Grth -
Income -352.09M Forward P/E -4.87 EPS next Y -1.40% 50D Avg Chg -3.00%
Sales 26.82M PEG -0.14 EPS past 5Y - 200D Avg Chg -2.00%
Dividend N/A Price/Book 1.39 EPS next 5Y 39.00% 52W High Chg -25.00%
Recommedations 2.10 Quick Ratio 11.49 Shares Outstanding 56.19M 52W Low Chg 23.00%
Insider Own 1.62% ROA -22.49% Shares Float 47.60M Beta 0.86
Inst Own 108.52% ROE -36.83% Shares Shorted/Prior 6.65M/6.85M Price 25.98
Gross Margin - Profit Margin - Avg. Volume 443,688 Target Price 42.80
Oper. Margin -1,496.23% Earnings Date May 2 Volume 377,945 Change -3.02%
About Agios Pharmaceuticals, Inc.

Agios Pharmaceuticals, Inc., a biopharmaceutical company, discovers and develops medicines in the field of cellular metabolism in the United States. Its lead product includes PYRUKYND (mitapivat), an activator of wild-type and mutant pyruvate kinase (PK), enzymes for the treatment of hemolytic anemias. The company develops AG-946, a PK activator for treating lower-risk myelodysplastic syndrome and hemolytic anemias; and AG-181, a phenylalanine hydroxylase stabilizer for the treatment of phenylketonuria. Its preclinical product is siRNA for the treatment of polycythemia vera, a rare blood disorder. Agios Pharmaceuticals, Inc. was incorporated in 2007 and is headquartered in Cambridge, Massachusetts.

Agios Pharmaceuticals, Inc. News
04/25/24 Analysts Estimate Agios Pharmaceuticals (AGIO) to Report a Decline in Earnings: What to Look Out for
04/18/24 Agios to Webcast Conference Call of First Quarter 2024 Financial Results on May 2, 2024
04/16/24 The 3 Best Biotech Stocks to Buy Now: Q2 Edition
04/10/24 Director Jacqualyn Fouse Sells Shares of Agios Pharmaceuticals Inc (AGIO)
04/09/24 Agios Publishes 2024 Environmental, Social and Governance (ESG) Report
03/30/24 We Think Agios Pharmaceuticals (NASDAQ:AGIO) Can Afford To Drive Business Growth
03/05/24 Agios to Present at the Leerink Partners Global Biopharma Conference on March 12, 2024
03:12 PM Agios Pharmaceuticals Stock Earns IBD Stock Upgrade Again, Hitting 90-Plus RS Rating
02/23/24 Agios Pharmaceuticals Stock Earns RS Rating Upgrade; Hits Key Benchmark
02/22/24 Agios to Present at the TD Cowen 44th Annual Health Care Conference on March 4, 2024
02/20/24 Agios Pharmaceuticals, Inc. (NASDAQ:AGIO) Q4 2023 Earnings Call Transcript
02/18/24 Agios Pharmaceuticals, Inc. (NASDAQ:AGIO) Just Reported And Analysts Have Been Cutting Their Estimates
02/17/24 Agios Pharmaceuticals, Inc. (NASDAQ:AGIO) Analysts Just Slashed This Year's Estimates
02/16/24 Agios (AGIO) Q4 Earnings & Revenues Fall Short of Estimates
02/15/24 Q4 2023 Agios Pharmaceuticals Inc Earnings Call
02/15/24 Agios Pharmaceuticals (AGIO) Reports Q4 Loss, Misses Revenue Estimates
02/15/24 Agios Pharmaceuticals Inc (AGIO) Reports Mixed Fourth Quarter and Full Year 2023 Financial Results
02/15/24 Agios Reports Fourth Quarter and Full Year 2023 Financial Results and Recent Business Highlights
02/14/24 Drug, Biotech Stock Q4 Earnings Due on Feb 15: ALNY, BPMC & More
02/08/24 Earnings Preview: Agios Pharmaceuticals (AGIO) Q4 Earnings Expected to Decline
AGIO Chatroom

User Image Tumble5 Posted - 16 minutes ago

$AGIO 🎹🎹🎹🎶🎶🎶🎵🎵🎵 “ it’s all coming back to me NOW “. Right Celine !!!!

User Image Tumble5 Posted - 19 minutes ago

$AGIO Don’t but yet, lol….goldman will drop it !

User Image Tumble5 Posted - 18 hours ago

$AGIO buy suggestion here ….wait till Goldman is out of stock, buyers pushed them , they will turn it RED quickly than to stretch to acquire inventory!!!

User Image Tumble5 Posted - 18 hours ago

$AGIO Great Break out , hahahaha …oh ya

User Image Tumble5 Posted - 19 hours ago

$AGIO too many buyers, no inventory….so, Goldman goes thru the losses than to stretch . WHY? They are SHORT

User Image Stu512 Posted - 1 day ago

$AGIO Hardly a Break Out !!! Some learn the hard way

User Image Pianomemo Posted - 2 days ago

$AGIO Some people learn it the hard way. Nice break out

User Image vu_jade Posted - 2 days ago

$AGIO nice entry look

User Image Pianomemo Posted - 3 days ago

$AGIO dude in here has no hobbies but will get wrecked in few months when this hits 52w highs

User Image Sweet_Action Posted - 3 days ago

$AGIO Stu IS the AGIO board!

User Image xbibackto70s Posted - 6 days ago

$AGIO adding more

User Image working_girl Posted - 6 days ago

$AGIO Wow people besides bots are actually posting on this board now? lol

User Image xbibackto70s Posted - 1 week ago

$AGIO adding some

User Image xbibackto70s Posted - 1 week ago

$AGIO nice chart

User Image vjtweet Posted - 1 week ago

$AGIO taking the trade above 30.

User Image Stock_Titan Posted - 1 week ago

$AGIO Agios to Webcast Conference Call of First Quarter 2024 Financial Results on May 2, 2024 https://www.stocktitan.net/news/AGIO/agios-to-webcast-conference-call-of-first-quarter-2024-financial-8106301u3h4o.html

User Image insiderbuyingselling Posted - 2 weeks ago

$AGIO new insider selling: 7791 shares. http://insiderbuyingselling.com/?t=AGIO

User Image Stock_Titan Posted - 2 weeks ago

$AGIO Agios Publishes 2024 Environmental, Social and Governance (ESG) Report https://www.stocktitan.net/news/AGIO/agios-publishes-2024-environmental-social-and-governance-esg-e8ryh4bakdbe.html

User Image RiskVsReward Posted - 2 weeks ago

A true thing of beauty.. $AGIO

User Image Baruke Posted - 2 weeks ago

$ESPR $AGIO $CCL $CADL true story. This is the resume @Stu52 tried to submit about a month ago. Obviously none of it is true, but it does turn out that he does have a job. He works out of some dudes garage outside some village in Singapore, sitting at a makeshift workbench with a bunch of minute-card cell phones rigged to a computer. If he doesn't make so many scam calls/texts/emails, he gets the hose again

User Image fda_tracker Posted - 3 weeks ago

$AGIO Phase 3 trial w/est Apr completion date NCT04770779: https://www.clinicaltrials.gov/study/NCT04770779 Trial Tracker: https://www.fdatracker.com/trial-tracker/

User Image chartsmarter Posted - 03/28/24

FULL BIOTECH GAME PLAN UP: https://www.chartsmarter.com/2024/03/28/healthcare-sector-review-4-1-24/ "once a month we show what we do daily. XBI needs to hold above very round 90 number. $IOVA reclaims 21-day EMA, $BPMC eyeing par, $AGIO puts in doji candle Thursday." $CRSP $BEAM TWST OSCR #biotech #StockMarket

User Image ViractaTrader77 Posted - 1 month ago

$MBRX incredible data 50-60% cr in second line AML https://www.streetinsider.com/dr/news.php?id=22971467&gfv=1 $AGIO

User Image ViractaTrader77 Posted - 1 month ago

$AGIO MBRX has $12 million valuation. Trading at 1/2 cash balance. 40% complete response in 2nd line Acute Myeloid Leukemia. FDA Fast Tracked Celator was first line and got bought for $1.5 Billion. https://player.vimeo.com/video/915686201?h=fb9d821f85 $ELEV $BDTX

User Image ViractaTrader77 Posted - 1 month ago

$MBRX Race Oncology’s drug Bisantrene for refractory AML is fetching them a $220 million aussie market cap. Moleculin at 12 million usd and a huge body of data and has patents pending until 2040 and 40% complete responders in second line aml. seems like a good speculative gamble here. $AGIO $PYXS

User Image ViractaTrader77 Posted - 1 month ago

$MBRX pending because of material news. look at Race Oncology on the Australian exchange went to $400 million market cap with 40% cr for aml in a 10 person study with their chemo drug. so this at $15 million is a complete joke valuation wise should be $400 million market cap. $AGIO sold subset aml mutation aml drugs for billions and celator was sold for billions. biggest mistake management made was listing on NASDAQ instead of australian exchange. plus this aml is fast tracked and could receive acclerated approval. its very not sexy because its not an ADC however it works like adc not toxic. so big pharma will be all over them.

User Image Stu512 Posted - 1 month ago

$AGIO Still a pathetic company for better than 7 years ….No leadership, no talent just “ would be” staff with serious flaws. Misfits if you will. Fidelity saw it, wellington saw it. Both sold out. Even insiders are selling shares down this low . Low 1.7B MC when good bio’s are at 4 or 5B , MC

User Image Stu512 Posted - 1 month ago

$AGIO GOFF , lol..your 25% vested Hire On options are RED….you be and the next CEO loser and bat !! Who’s on deck ??? Pee Wee Herman ???? Fouse her 5 year 40k shares at $30@ are RED…but that was her own fault , lol … Schenkien got 50% of what he authorized to pay Bristol $48.75 Senior mgmt team of losers

User Image Stu512 Posted - 1 month ago

$AGIO Gee GOFF , you have a bit to pay your taxes on your, 29.38 options , lol. That chump change is all your worth in 20 months of NO VALUE

User Image Aigner_Andreas Posted - 1 month ago

TD BUY $AGIO at 30.29, Supp 29.78 Resis 34.81 R17 HiLo 70% T1Y 34 buy 2.4 DIV N/A #Agios Phar #stocks #trading #finance #market

Analyst Ratings
Cantor Fitzgerald Overweight Apr 9, 24
JP Morgan Neutral Feb 23, 24
RBC Capital Outperform Feb 16, 24
Goldman Sachs Neutral Nov 3, 23
JP Morgan Neutral Aug 7, 23
RBC Capital Outperform Jun 27, 23
Piper Sandler Overweight Feb 3, 23
JP Morgan Neutral Dec 1, 22
Goldman Sachs Neutral Nov 17, 22
Insider Trades Relationship Date Transactions Cost($) #Shares Value($) #Share Own SEC Form 4
Schenkein David P Director Director Mar 27 Sell 22.15 20,000 443,000 117,879 03/29/23
Schenkein David P Director Director Mar 27 Option 9.05 20,000 181,000 137,879 03/29/23
Schenkein David P Director Director Mar 13 Sell 22.6 20,000 452,000 117,879 03/15/23
Schenkein David P Director Director Mar 13 Option 9.05 20,000 181,000 137,879 03/15/23
Washburn Theodore James Jr. Principal Accounting.. Principal Accounting Officer Feb 25 Sell 30 108 3,240 2,549 03/01/22
Washburn Theodore James Jr. Principal Accounting.. Principal Accounting Officer Feb 14 Option 0 360 3,413 02/16/22
Washburn Theodore James Jr. Principal Accounting.. Principal Accounting Officer Feb 14 Sell 31.25 504 15,750 2,782 02/16/22
Bowden Christopher Chief Medical Office.. Chief Medical Officer Jun 21 Option 39.76 2,502 99,480 17,989 06/21/21
Bowden Christopher Chief Medical Office.. Chief Medical Officer Jun 21 Sell 60.02 2,502 150,170 15,487 06/21/21
Bowden Christopher Chief Medical Office.. Chief Medical Officer Apr 21 Option 36.69 17,611 646,148 29,888 04/21/21